Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
Sitala seals $670M deal for Fosun immune disease drug
Right on the heels of a similar deal, Fosun Pharma has outlicensed a second inflammatory disease candidate to a Western biotech startup.
Angus Liu
Aug 26, 2025 2:44pm
Jazz pays Saniona $42.5M to add prospect to epilepsy ensemble
Aug 20, 2025 9:13am
VantAI plays matchmaker for Halda's RIPTACs in $1B deal
Aug 19, 2025 8:00am
RemeGen sells Asia rights to VEGF/FGF eye drug in $180M deal
Aug 19, 2025 7:18am
Genentech scraps $2B cell therapy pact with Adaptive
Aug 18, 2025 2:40pm
Merck KGaA swoops to $2B neurological disease pact with Skyhawk
Aug 18, 2025 9:49am
